tm
Seeing Is Believing
tm
Seeing Is Believing
CLRB is currently covered by 3 analysts with an average price target of $10.25. This is a potential upside of $9.03 (740.16%) from yesterday's end of day stock price of $1.22.
Cellectar Biosciences's activity chart (see below) currently has 15 price targets and 19 ratings on display. The stock rating distribution of CLRB is 33.33% HOLD and 66.67% BUY.
Analysts average stock forecasts to be materialized ratio is 35.71% with an average time for these price targets to be met of 106.86 days.
Highest price target for CLRB is $11, Lowest price target is $10, average price target is $10.25.
Most recent stock forecast was given by KEVIN DEGEETER from LADENBURG on 15-May-2026. First documented stock forecast 02-May-2019.
Currently out of the existing stock ratings of CLRB, 1 are a HOLD (33.33%), 2 are a BUY (66.67%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jul-2020
$10
$8.75 (700.00%)
$1650
5 months 26 days ago
(15-May-2026)
0/3 (0%)
$6.91 (223.62%)
Buy Since 27-Apr-2021
$11
$9.75 (780.00%)
6 months 5 days ago
(05-May-2026)
0/2 (0%)
$7.82 (245.91%)
Hold Since 10-Mar-2026
$10
$8.75 (700.00%)
8 months ago
(10-Mar-2026)
0/2 (0%)
$6.95 (227.87%)
Hold Since 13-Jan-2025
1 years 9 months 28 days ago
(13-Jan-2025)
3/6 (50%)
$-36.3 (-75.16%)
125
Buy Since 02-May-2019
$90
$86.76 (2677.78%)
4 years 7 days ago
(04-Nov-2022)
1/1 (100%)
$33.3 (58.73%)
430
What is CLRB (Cellectar Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on CLRB (Cellectar Biosciences)?
Which analyst has the current lower performing score on CLRB (Cellectar Biosciences) with a proven track record?
Which analyst has the most public recommendations on CLRB (Cellectar Biosciences)?
Which analyst is the currently most bullish on CLRB (Cellectar Biosciences)?
Which analyst is the currently most reserved on CLRB (Cellectar Biosciences)?
